Treatment of chronic respiratory failure: Lung volume reduction surgery versus rehabilitation

European Respiratory Journal, Supplement

Volumn 22, Issue 47, 2003, Pages

  Decramer, M ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Chronic obstructive pulmonary; Disease; Exercise capacity; Health status; Lung volume reduction surgery; Rehabilitation; Selection of candidates

Indexed keywords

ANABOLIC AGENT; CARBON DIOXIDE; CYTOKINE; CYTOKINE ANTIBODY; GROWTH HORMONE; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; INTERLEUKIN 8; INTERLEUKIN 8 ANTIBODY; NANDROLONE DECANOATE; OXYGEN; SOMATOMEDIN C; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY FAILURE; CLINICAL TRIAL; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DAILY LIFE ACTIVITY; EDUCATION PROGRAM; EMPHYSEMA; EXERCISE; FORCED EXPIRATORY VOLUME; GRIP STRENGTH; HEALTH STATUS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HOSPITAL ADMISSION; HUMAN; LUNG FUNCTION; LUNG MECHANICS; LUNG RESECTION; LUNG SCINTISCANNING; MUSCLE STRENGTH; NUTRITION; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RESIDUAL VOLUME; TOTAL LUNG CAPACITY; VITAL CAPACITY; WALKING; ARTIFICIAL VENTILATION; CHRONIC DISEASE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; FEMALE; HOSPITALIZATION; LUNG FUNCTION TEST; LUNG VOLUME; MALE; METHODOLOGY; MORTALITY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; REVIEW; RISK ASSESSMENT; STATISTICS; SURVIVAL; TREATMENT OUTCOME;

CHRONIC DISEASE; FEMALE; HUMANS; LUNG VOLUME MEASUREMENTS; MALE; PNEUMONECTOMY; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIALS; RESPIRATORY FUNCTION TESTS; RESPIRATORY INSUFFICIENCY; RESPIRATORY THERAPY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0242322682     PISSN: 09041850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (123)

1. Pauwels R, Buist A, Calverley P, Jenkins R, Hurd S, on behalf of the GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1256-1276.
2. Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994; 272: 1497-1505.
3. Boyd G, Morice AH, Pounsford JC, Siebert M, Peslis N, Crawford C. An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD). Eur Respir J 1997; 10: 815-821.
4. Vincken W, van Noord JA, Greefhorst APM, et al. Improved health outcomes in patients with COPD during 1 year's treatment with tiotropium Eur Respir J 2002; 19: 209-216.
5. Dahl R, Greefhorst L, Nowak D, et al., on behalf of the Formoterol in Chronic Obstructive Pulmonary Disease I (FICOPD I) Study Group. Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 778-784.
6. Pauwels RA, Lofdahl CG, Laitinen LA, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. New Engl J Med 1999; 340: 1948-1953.
7. Vestbo J, Sorensen T, Lange P, Brix A, Torre P, Viskum K. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 1999; 353: 1819-1823.
8. Burge PS, Calverley PMA, Jones PW, Spencer S, Anderson JA, Maslen TK, on behalf of the ISOLDE study investigators. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000; 320: 1297-1303.
9. The Lung Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 2000; 343: 1902-1909.
10. Sin DD, Tu JV. Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 580-584.
11. Cooper JD, Trulock EP, Triantafillou AN, et al. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1995; 109: 106-119.
12. Cooper JD, Patterson GA, Sundaresan RS, et al. Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg 1996; 112: 1319-1329.
13. Rennard S, Decramer M, Calverley PMA, et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 2002; 20: 799-805.
14. Garcia-Aymerich J, Barreiro E, Farrero E, Marrades RM, Morera J, Antó JM, and the EFRAM investigators. Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study). Eur Respir J 2000; 16: 1037-1042.
15. Rennard S, Carrera M, Agustí AGN. Management of chronic obstructive pulmonary disease: are we going anywhere? Eur Respir J 2000; 16: 1035-1036.
16. Lau CL, Patterson GA. Current status of lung transplantation. Eur Respir J 2003; 22: Suppl. 47, 57s-64s.
17. Goldstein RS, Gort EH, Stubbing D, Avendano MA, Guyatt CH. Randomized controlled trial of respiratory rehabilitation. Lancet 1994; 344: 1394-1397.
18. Ries AL, Kaplan RM, Limberg TMK, Prewitt LM. Effects of pulmonary rehabilitation on physiological and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 1995; 122: 823-832.
19. Lacasse Y, Wong E, Guyatt GH, King D, Cook DJ, Goldstein RS. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996; 348: 1115-1119.
20. Wedzicha JA, Bestall JC, Garrod R, Garnham R, Paul EA. Jones PW. Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale. Eur Respir J 1998; 12: 363-369.
21. Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH. Interpreting a small difference in functional status: the six-minute walking test in chronic lung disease patients. Am J Respir Crit Care Med 1997; 155: 1278-1282.
22. Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 2002; 19: 390-391.
23. Griffiths TL, Burr ML, Campbell IA, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000; 355: 362-368.
24. Troosters T, Gosselink R, Decramer M. Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomised trial. Am J Med 2000; 109: 207-212.
25. Lacasse Y, Brosseau L, Milne S, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2002; CD003793.
26. Griffiths TL, Phillips CJ, Davies S, Burr ML, Campbell IA. Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme. Thorax 2001; 56: 779-784.
27. Wedzicha JA, Seemungal TA, MacCallum PK, Paul EA, Jones PW. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost 2000; 84: 210-215.
28. Troosters T, Gosselink R, De Paepe K, Decramer M. Pulmonary rehabilitation improves survival in COPD patients with a recent severe acute exacerbation. Am J Respir Crit Care Med 2002; 165: A16.
29. Troosters T, Gosselink R, Decramer M. Exercise training in COPD: how to distinguish responders from nonresponders. J Cardiopulm Rehabil 2001; 21: 10-17.
30. ZuWallack RL. Selection criteria and outcome assessment in pulmonary rehabilitation. Monaldi Arch Chest Dis 1998; 53: 429-437.
31. Morgan MDL. The prediction of benefit from pulmonary rehabilitation: setting, training intensity and the effect of selection by disability. Thorax 1999; 54: Suppl. 2, S3-S7.
32. ZuWallack RL, Patel K, Reardon JZ, Clarck BA, Normandin EA. Predictors of improvement in the 12-minute walking distance following a six-week outpatient pulmonary rehabilitation program. Chest 1991; 99: 805-808.
33. Maltais F, LeBlanc P, Jobin J, et al. Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 155: 555-561.
34. Casaburi R, Porszasz J, Burns MR, Carithers ER, Chang RS, Cooper CB. Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 155: 1541-1551.
35. Belman MJ, Kendregan BA. Exercise training fails to increase skeletal muscle enzymes in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1981; 123: 256-261.
36. Berry MJ, Rejeski WJ, Adair NE, Zaccaro D. Exercise rehabilitation and chronic obstructive pulmonary disease stage. Am J Respir Crit Care Med 1999; 160: 1248-1253.
37. Young P, Dewse M, Fergusson W, Kolbe J. Respiratory rehabilitation in chronic obstructive pulmonary disease: predictors of nonadherence. Eur Respir J 1999; 13: 855-859.
38. Wijkstra PJ, van der Mark TW, Kraan J, van Altena R, Koeter GH, Postma DS. Long-term effects of home rehabilitation on physical performance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 1234-1241.
39. Lacasse Y, Guyatt GH, Goldstein RS. The components of a respiratory rehabilitation program: a systematic overview. Chest 1997; 111: 1077-1088.
40. Vogiatzis I, Nanas S, Roussos C. Interval training as an alternative modality to continuous exercise in patients with COPD. Eur Respir J 2002; 20: 12-19.
41. Simpson K, Killian K, McCartney N, Stubbing DG, Jones NL. Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation. Thorax 1992; 47: 70-75.
42. Bernard S, Whittom F, Leblanc P. et al. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 896-901.
43. Ortega F, Toral J, Cejudo P, et al. Comparison of effects of strength and endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 669-674.
44. Spruit MA, Gosselink R, Troosters T, De Paepe C, Decramer M. Resistance versus endurance training in patients with COPD and peripheral muscle weakness. Eur Respir J 2002; 19: 1072-1078.
45. Neder JA, Sword D, Ward SA, Mackay E, Cochrane LM, Clarck CJ. Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD). Thorax 2002; 57: 333-337.
46. Bourjeily-Habr G, Rochester CL, Palermo F, Snyder P, Mohensin V. Randomised controlled trial of transcutaneous electrical muscle stimulation of the lower extremities in patients with chronic obstructive pulmonary disease. Thorax 2002; 57: 1045-1049.
47. Smith K, Cook D, Guyatt GH, Madhavan J, Oxman AD. Respiratory muscle training in chronic airflow limitation: a meta-analysis. Am Rev Respir Dis 1992; 145: 533-539.
48. Wanke T, Formanek D, Lahrmann H, et al. Effects of combined inspiratory muscle and cycle ergometer training on exercise performance in patients with COPD. Eur Respir J 1994; 7: 2205-2211.
49. Rooyackers JM, Dekhuijzen PN, Van Herwaarden CL, Folgering HT. Training with supplemental oxygen in patients with COPD and hypoxaemia at peak exercise. Eur Respir J 1997; 10: 1278-1284.
50. Garrod R, Paul EA, Wedzicha JA. Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia. Thorax 2000; 55: 539-543.
51. Wadell K, Henriksson-Larsen K, Lundgren R. Physical training with and without oxygen in patients with chronic obstructive pulmonary disease and exercise-induced hypoxaemia. J Rehabil Med 2001; 33: 200-205.
52. Johnson JE, Gavin DJ, Adams-Dramiga S. Effects of training with heliox and noninvasive positive pressure ventilation on exercise ability in patients with severe COPD. Chest 2002; 122: 464-472.
53. Hawkins P, Johnson LC, Nikoletou D, et al. Proportional assist ventilation as an aid to exercise training in severe chronic obstructive pulmonary disease. Thorax 2002; 57: 853-859.
54. Burdet L, de Muralt B, Schutz Y, Pichard C, Fitting JW. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. Am J Respir Crit Care Med 1997; 156: 1800-1806.
55. Schols AM, Soeters PB, Mostert R, Pluymers J, Wouters EF. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med 1995; 152: 1268-1274.
56. Casaburi R, Cosentino G, Bhasin S, et al. A randomized trial of strength training and testosterone supplementation in men with chronic obstructive pulmonary disease. Eur Respir J 2001; 18: Suppl. 33, A173.
57. Schols AM, Buurman WA, Staal van den Brekel AJ, Dentener MA, Wouters EF. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996; 51: 819-824.
58. Di Francia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factor- α levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 150: 1453-1455.
59. Spruit MA, Gosselink R, Troosters T, et al. Effects of an acute exacerbation requiring hospitalisation (AE) on lung function, muscle force and serum IGF-I levels in male patients with chronic obstructive pulmonary disease (COPD). Eur Respir J 2002; 20: Suppl. 38, 564S (abstract).
60. Flaherty KR, Martinez FJ. Lung volume reduction surgery for emphysema. Clin Chest Med 2000; 21: 819-848.
61. Stirling GR, Babidge WJ, Peacock MJ, et al. Lung volume reduction surgery in emphysema: a systematic review. Ann Thorac Surg 2001; 72: 641-648.
62. Berger RL, Celli BR, Meneghetti AL, et al. Limitations of randomized clinical trials for evaluating emerging operations: the case of lung volume reduction surgery. Ann Thorac Surg 2001; 72: 649-657.
63. McKenna RJ, Gelb A, Brenner M. Lung volume reduction surgery for chronic obstructive pulmonary disease: where do we stand? World J Surg 2001; 25: 231-237.
64. McKenna RJ, Brenner M, Fischel RJ, Gelb AF. Should lung volume reduction for emphysema be unilateral or bilateral? J Thorac Cardiovasc Surg 1996; 112: 1331-1338.
65. Hazelrigg SR, Boley TM, Naunheim KS, et al. Effect of bovine pericardial strips on air leak after stapled pulmonary resection. Ann Thorac Surg 1997; 63: 1573-1575.
66. The National Emphysema Treatment Trial Research Group. Rationale and design of the national emphysema treatment trial. J Cardiopulm Rehabil 2000; 20: 24-36.
67. Geddes D, Davies M, Koyama H, et al. Effect of lung-volume-reduction surgery in patients with severe emphysema. N Engl J Med 2000; 343: 239-245.
68. Criner GJ, Cordova FC, Furukawa S, et al. Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 2018-2027.
69. Pompeo E, Marino M, Nofroni I, Matteucci G, Mineo TC. Reduction pneumoplasty versus respiratory rehabilitation in severe emphysema: a randomized study. Ann Thorac Surg 2000; 70: 948-954.
70. National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med 2001; 345: 1075-1083.
71. Goodnight-White S, Jones JW, Baaklini WA. Prospective, randomised, controlled trial comparing bilateral lung volume reduction surgery (LVRS) to medical therapy alone in patients with severe emphysema. Chest 2000; 118: Suppl. 4, 102S (abstract).
72. Löfdahl CG, Hillerdal G, Ström K. Randomized controlled trial of volume reduction surgery - preliminary results up to 12 months. Am J Respir Crit Care Med 2000; 161: A585.
73. Criner GJ, O'Brien G, Furukawa S, et al. Lung volume reduction surgery in ventilator-dependent COPD patients. Chest 1996; 110: 877-884.
74. Teschler H, Stamatis G, el-Raouf Farhat AA, Meyer FJ, Costabel U, Konietzko N. Effect of surgical lung volume reduction on respiratory muscle function in pulmonary emphysema. Eur Respir J 1996; 9: 1779-1784.
75. Martinez FJ, de Oca MM, Whyte RI, Stetz J, Gay E, Celli BR. Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. Am J Respir Crit Care Med 1997; 155: 1984-1990.
76. Bellemare F, Cordeau MP, Couture J, Lafontaine E, Leblanc P, Passerini L. Effects of emphysema and lung volume reduction surgery on transdiaphragmatic pressure and diaphragm length. Chest 2002; 121: 1898-1910.
77. Marchand E, De Leyn P, Gayan-Ramirez G, et al. Lung volume reduction surgery does not improve diaphragmatic contractile properties or atrophy in hamsters with elastase-induced emphysema. Am J Respir Crit Care Med 2000; 162: 1052-1057.
78. Cassart M, Hamacher J, Verbandt Y, et al. Effects of lung volume reduction surgery for emphysema on diaphragm dimensions and configuration. Am J Respir Crit Care Med 2001; 163: 1171-1175.
79. Marchand E, Gayan-Ramirez G, De Leyn P, Decramer M. Physiological basis of improvement after lung volume reduction surgery for severe emphysema: where are we? Eur Respir J 1999; 13: 686-696.
80. Sciurba FC, Rogers RM, Keenan RJ, et al. Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema. N Engl J Med 1996; 334: 1095-1099.
81. Gelb AF, Zamel N, McKenna RJ Jr, Brenner M. Mechanism of short-term improvement in lung function after emphysema resection. Am J Respir Crit Care Med 1996; 154: 945-951.
82. Tschernko EM, Wisser W, Wanke T, et al. Changes in ventilatory mechanics and diaphragmatic function after lung volume reduction surgery in patients with COPD. Thorax 1997; 52: 545-550.
83. Fessler HE, Permutt S. Lung volume reduction surgery and airflow limitation. Am J Respir Crit Care Med 1998; 157: 715-722.
84. Loring SH, Leith DE, Connolly MJ, Ingenito EP, Mentzer SJ, Reilly JJ Jr. Model of functional restriction in chronic obstructive pulmonary disease, transplantation, and lung reduction surgery. Am J Respir Crit Care Med 1999; 160: 821-828.
85. Ingenito EP, Loring SH, Moy ML, Mentzer SJ, Swanson SJ, Reilly JJ. Interpreting improvement in expiratory flows after lung volume reduction surgery in terms of flow limitation theory. Am J Respir Crit Care Med 2001; 163: 1074-1080.
86. Marchand E, De Leyn P, Gayan-Ramirez G, Palecek F, Verbeken E, Decramer M. Effects of lung volume reduction surgery in hamsters with elastase-induced emphysema. Eur Respir J 2002; 19: 422-428.
87. Fessler HE, Scharf SM, Permutt S. Improvement in spirometry following lung volume reduction surgery: application of a physiologic model. Am J Respir Crit Care Med 2002; 165: 34-40.
88. Ingenito EP, Loring SH, Moy ML, Mentzer SJ, Swanson SJ, Reilly RR. Physiological charcterization of variability in response to lung volume reduction surgery. J Appl Physiol 2003; 94: 20-30.
89. Gelb AF, McKenna RJ Jr, Brenner M, Epstein JD, Zamel N. Lung function 5 yr after lung volume reduction surgery for emphysema. Am J Respir Crit Care Med 2001; 163: 1562-1566.
90. Fujimoto T, Teschler H, Hillejan L, Zaboura G, Stamatis G. Long-term results of lung volume reduction surgery. Eur J Cardiothorac Surg 2002; 21: 483-488.
91. Fessler HE, Wise RA. Lung volume reduction surgery: is less really more? Am J Respir Crit Care Med 1999; 159: 1031-1035.
92. Kesten S, Elpern E, Warren W, Szidon P. Loss of pulmonary function gains after lung volume reduction surgery. J Heart Lung Transplant 1999; 18: 266-268.
93. Brenner M, McKenna R Jr, Gelb A, et al. Objective predictors of response for staple versus laser emphysematous lung reduction. Am J Respir Crit Care Med 1997; 155: 1295-1301.
94. Thurnheer R, Engel H, Weder W, et al. Role of lung perfusion scintigraphy in relation to chest computed tomography and pulmonary function in the evaluation of candidates for lung volume reduction surgery. Am J Respir Crit Care Med 1999; 159: 301-310.
95. McKenna RJ Jr, Brenner M, Fischel RJ, et al. Patient selection criteria for lung volume reduction surgery. J Thorac Cardiovasc Surg 1997; 114: 957-967.
96. McKenna RJ Jr, Fischel RJ, Brenner M, Gelb AF. Combined operations for lung volume reduction surgery and lung cancer. Chest 1996; 110: 885-888.
97. Schmid RA, Stammberger U, Hillinger S, et al. Lung volume reduction surgery combined with cardiac interventions. Eur J Cardiothorac Surg 1999; 15: 585-591.
98. Lefrak SS, Yusen RD, Trulock EP, Pohl MS, Patterson A, Cooper JD. Recent advances in surgery for emphysema. Annu Rev Med 1997; 48: 387-398.
99. Mineo TC, Pompeo E, Rogliani P, et al. Effect of lung volume reduction surgery for severe emphysema on right ventricular function. Am J Respir Crit Care Med 2002; 165: 489-494.
100. 1-antitrypsin deficiency versus smoker's emphysema. Eur Respir J 1998; 12: 1028-1032.
101. Teschler H, Thompson AB, Stamatis G. Short- and long-term functional results after lung volume reduction surgery for severe emphysema. Eur Respir J 1999; 13: 1170-1176.
102. 1-antitrypsin emphysema. Eur Respir J 1999; 14: 928-933.
103. Ingenito EP, Evans RB, Loring SH, et al. Relation between preoperative inspiratory lung resistance and the outcome of lung-volume-reduction surgery for emphysema. N Engl J Med 1998; 338: 1181-1185.
104. Ferguson GT, Fernandez E, Zamora MR, Pomerantz M, Buchholz J, Make BJ. Improved exercise performance following lung volume reduction surgery for emphysema. Am J Respir Crit Care Med 1998; 157: 1195-1203.
105. Szekely LA, Oelberg DA, Wright C, et al. Preoperative predictors of operative morbidity and mortality in COPD patients undergoing bilateral lung volume reduction surgery. Chest 1997; 111: 550-558.
106. Argenziano M, Moazami N, Thomashow B, et al. Extended indications for lung volume reduction surgery in advanced emphysema. Ann Thorac Surg 1996; 62: 1588-1597.
107. O'Brien G, Furukawa S, Kuzma AM, Cordova F, Criner GJ. Improvements in lung function, exercise, and quality of life in hypercapnic COPD patients after lung volume reduction surgery. Chest 1999; 115: 75-84.
108. Wisser W, Klepetko W, Senbaklavaci O, et al. Chronic hypercapnia should not exclude patients from lung volume reduction surgery. Eur J Cardiothorac Surg 1998; 14: 107-112.
109. Weder W, Thurnheer R, Stammberger U, Burge M, Russi EW, Bloch KE. Radiologic emphysema morphology is associated with outcome after surgical lung volume reduction. Ann Thorac Surg 1997; 64: 313-320.
110. Hamacher J, Bloch KE, Stammberger U, et al. Two years' outcome of lung volume reduction surgery in different morphologic emphysema types. Ann Thorac Surg 1999; 68: 1792-1798.
111. Wisser W, Klepetko W, Kontrus M, et al. Morphologic grading of the emphysematous lung and its relation to improvement after lung volume reduction surgery. Ann Thorac Surg 1998; 65: 793-799.
112. Ingenito EP, Loring SH, Moy ML, et al. Comparison of physiological and radiological screening for lung volume reduction surgery. Am J Respir Crit Care Med 2001; 163: 1068-1073.
113. Nakano Y, Coxson HO, Bosan S, et al. Core to rind distribution of severe emphysema predicts outcome of lung volume reduction surgery. Am J Respir Crit Care Med 2001; 164: 2195-2199.
114. Cooper JD, Patterson GA. Lung volume reduction surgery for severe emphysema. Semin Thorac Cardiovasc Surg 1996; 8: 52-60.
115. Dartevelle P, Macchiarini P, Chapelier A. Operative technique of bullectomy. Chest Surg Clin North Am 1995; 5: 735-749.
116. Klepetko W. Surgical aspects and techniques of lung volume reduction surgery for severe emphysema. Eur Respir J 1999; 13: 919-925.
117. Krucylak PE, Keller CA, Naunheim KS. Current status of thoracoscopic lung volume reduction. World J Surg 1999; 23: 1148-1155.
118. McKenna RJ Jr, Brenner M, Gelb AF, et al. A randomized, prospective trial of stapled lung reduction versus laser bullectomy for diffuse emphysema. J Thorac Cardiovasc Surg 1996; 111: 317-322.
119. Swanson SJ, Mentzer SJ, DeCamp MM Jr, et al. No-cut thoracoscopic lung plication: a new technique for lung volume reduction surgery. J Am Coll Surg 1997; 185: 25-32.
120. Drazen JM. Surgery for emphysema - not for everyone. N Engl J Med 2001; 345: 1126-1128.
121. Brenner M, Gonzalez X, Jones B, et al. Effects of a novel implantable elastomer device for lung volume reduction surgery in a rabbit model of elastase-induced emphysema. Chest 2002; 121: 201-209.
122. Toma TP, Hopkinson NS, Hillier J, et al. Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet 2003; 361: 931-933.
123. Ingenito EP, Reilly JJ, Mentzer SJ, et al. Bronchoscopic volume reduction: a safe and effective alternative to surgical therapy for emphysema. Am J Respir Crit Care Med 2001; 164: 295-301.